Li Wang
University of North Carolina at Chapel Hill(US)Beijing Hua Xin Hospital(CN)Imaging Center(US)
Publications by Year
Research Areas
Peroxisome Proliferator-Activated Receptors, Lipoproteins and Cardiovascular Health, Traditional Chinese Medicine Analysis, Adipose Tissue and Metabolism, Cholesterol and Lipid Metabolism
Most-Cited Works
- → Effects of sodium‐glucose co‐transporter 2 ( SGLT2 ) inhibitors on serum uric acid level: A meta‐analysis of randomized controlled trials(2017)322 cited
- → MicroRNAs 185, 96, and 223 Repress Selective High-Density Lipoprotein Cholesterol Uptake through Posttranscriptional Inhibition(2013)155 cited
- → Butyrate protects against high‐fat diet‐induced atherosclerosis via up‐regulating ABCA1 expression in apolipoprotein E‐deficiency mice(2019)151 cited
- → Molecular characterization of the role of orphan receptor small heterodimer partner in development of fatty liver(2007)147 cited
- → Berberine attenuates choline-induced atherosclerosis by inhibiting trimethylamine and trimethylamine-N-oxide production via manipulating the gut microbiome(2021)135 cited
- → Molecular link between glucose and glutamine consumption in cancer cells mediated by CtBP and SIRT4(2018)111 cited